Subscribe to RSS
DOI: 10.1055/s-0028-1087518
Heterocyclizations via TosMIC-Based Multicomponent Reactions: A New Approach to One-Pot Facile Synthesis of Substituted Quinoxaline Derivatives
Publication History
Publication Date:
15 January 2009 (online)
Abstract
A novel multicomponent reaction involving o-phenylenediamines, aldehydes and p-toluenesulfonylmethyl isocyanide (TosMIC) in the presence of a base leading to the formation of quinoxalines in very good yields is described.
Key words
multicomponent reactions - TosMIC - quinoxalines
Quinoxalines are widely used as intermediates in medicinal chemistry, [¹] [²] since they exhibit a wide range of biological activities, such as antiviral, antibacterial, anti-inflammatory and kinase inhibitor properties. [³-¹0] The echinomycin [¹¹] and the triostins [¹²] are well-known antibiotic families of quinoxaline derivatives. Furthermore, they have found applications as dyes, [¹³a] efficient electroluminescent materials, [¹³b] organic semiconductors, [¹³c] dehydroannulenes, [¹³d] cavidands [¹³e] and chemically controllable switches. [¹³f] Thus, a number of methods have been developed for the synthesis of substituted quinoxalines involving condensation of 1,2-phenylenediamines with α-diketones, also under microwave irradiation, [¹4] 1,4-addition of 1,2-diamines to diazenylbutenes, [¹5] oxidation trapping of α-hydroxyketones with 1,2-diamines, [¹6] oxidative cyclization of phenacyl bromides [¹7] or vicinal diols with o-phenylenediamines, [¹8] oxidative coupling of epoxides [¹9] or ketones [²0] with 1,2-diamines. Very recently, quinoxalines were also synthesized in 33-55% yield, through a two-step reaction sequence, the first step involving a multicomponent reaction between o-phenylenediamines, aldehydes and isonitriles in hydrochloric methanolic solution, whereas in the second step a DDQ oxidation of the isolated dihydroquinoxalines was involved. [²¹]
Sequential transformations and one-pot multicomponent reactions (MCRs) offer significant advantages over conventional linear step syntheses, by reducing time and saving money, energy and raw material thus resulting in both economic and environmental benefits. [²²] Moreover, multicomponent synthesis has been established as a valuable tool to the pharmaceutical industry for construction of low molecular weight compound libraries through combinatorial strategies and parallel synthesis. [²³] Although p-toluenesulfonylmethyl isocyanide (TosMIC) is a versatile, widely applicable reagent that constitutes a densely functionalized building block bearing an active methylene group apart from its inherent advantage of possessing also an isonitrile functionality, which can serve as a handle for further manipulation, the possibility of its use in multicomponent reactions has not been greatly appreciated. TosMIC has most commonly been used in heterocyclic ring construction, [²4] in particular, of oxazole and pyrrole moieties, but comparatively rarely in multicomponent reactions. [²5]
Since the reaction between imines and TosMIC in basic media constitutes a trusted method for the synthesis of 1,5-disubstituted imidazoles [²6] and in continuation to our previous work [²7] we speculated that formation of quinoxalines would be possible, through a multicomponent reaction, by using o-phenylenediamines with equimolar amounts of an aldehyde and TosMIC.
Initially, a three-component reaction was performed between o-phenylenediamine, benzaldehyde and TosMIC in the presence of DBU as base, using toluene as solvent at room temperature for eight hours to afford the quinoxaline 3a in 45% yield along with the classical benzaldehyde-TosMIC reaction product, the oxazole 4a in 40% yield. In order to minimize the oxazole formation, the reaction was repeated by heating at 80 ˚C for four hours (Scheme [¹] ), whereupon the yield of 3a was improved considerably (65%), whereas that of 4a was decreased to 27%. By using a milder base, DABCO instead of DBU, the optimum yield of 3a (91%) was achieved. However, in the presence of other bases, such as Et3N and K2CO3, the three-component reaction did not take place, so in the first case only N-benzyl-2-phenylbenzimidazole was isolated (45% yield), whereas in the second only the oxazole 4a in 74% yield.
Concerning the experimental procedure, a TosMIC-base toluene solution was added to an o-phenylenediamine-benzaldehyde solution, which had already been stirred for five minutes. The reaction also proceeded, but with lower yields, by simultaneously mixing all of the reactants. In contrast, initial stirring of o-phenylenediamine-benzaldehyde for longer periods resulted in substantially lower yields, most probably because of double Schiff base formation. This hypothesis is supported by the fact that quinoxaline 3 was not formed after an initial stirring for two hours.
Having established the best protocol for the formation of 3, all subsequent reactions were performed by using DABCO, although in some cases for comparison purposes the reactions were also repeated with DBU, and the results are presented in Table [¹] (entries 1-8). Analogous results were obtained by using the chloro-substituted diamine (entries 9 and 10), whereas by using the dimethyl-substituted diamine the quinoxaline yields were optimized, when the stronger base DBU was used (entries 11-13). DBU was also the best base, when heterocyclic aldehydes were used (entries 14-18), though the yields were generally lower. Finally, the bulky anthracenealdehyde reacted analogously (entries 19 and 20).

Scheme 1 Reagents and conditions: DBU or DABCO, toluene 80 ˚C, 4 h
Entry | R¹ | R² | Ar | Base | Quinoxaline (%) | Oxazole (%) | |||||||||||||
1 | H | H | phenyl | DBU | 3a (65) | 4a (27) | |||||||||||||
2 | H | H | phenyl | DABCO | 3a (91) | - | |||||||||||||
3 | H | H | 2-methylphenyl | DABCO | 3b (89) | - | |||||||||||||
4 | H | H | 2,4-dimethylphenyl | DABCO | 3c (81) | - | |||||||||||||
5 | H | H | 4-methoxyphenyl | DABCO | 3d (82) | - | |||||||||||||
6 | H | H | 4-chlorophenyl | DBU | 3e (63) | 4e (30) | |||||||||||||
7 | H | H | 4-chlorophenyl | DABCO | 3e (84) | - | |||||||||||||
8 | H | H | 4-nitrophenyl | DABCO | 3f (80) | 4f (10) | |||||||||||||
9 | H | Cl | phenyl | DBU | 3g (45)a | 4a (56) | |||||||||||||
10 | H | Cl | phenyl | DABCO | 3g (79)a | 4a (16) | |||||||||||||
11 | Me | Me | phenyl | DBU | 3h (86) | - | |||||||||||||
12 | Me | Me | phenyl | DABCO | 3h (72) | 4a (trace) | |||||||||||||
13 | Me | Me | 2-methylphenyl | DBU | 3i (85) | - | |||||||||||||
14 | H | H | 2-furyl | DBU | 3j (46) | 4j (40) | |||||||||||||
15 | H | H | 2-thienyl | DBU | 3k (47) | 4k (40) | |||||||||||||
16 | H | H | 2-thienyl | DABCO | 3k (trace) | - | |||||||||||||
17 | H | H | 3-thienyl | DBU | 3l (49) | 4l (40) | |||||||||||||
18 | H | H | 3-thienyl | DABCO | 3l (trace) | - | |||||||||||||
19 | H | H | 9-anthryl | DBU | 3m (52) | 4m (42) | |||||||||||||
20 | H | H | 9-anthryl | DABCO | 3m (trace) | - | |||||||||||||
| |||||||||||||||||||
a Isolated
as a mixture of regioisomers in ca. 1:2 ratio. |
From a careful inspection of the results given in Table [¹] it can be concluded that the outcome of the competitive reactions (quinoxaline versus oxazole formation) depends not only on the substituents of the diamine and the aldehyde, affecting the extent of imine (Shiff base) formation (entries 1 vs. 2, 6 vs. 7 and 11 vs. 12), but also on the strength of the base, which affects the rate and the extent of the TosMIC anion formation, thus reacting more readily with aldehydes carrying electron-withdrawing substituents.
Quinoxaline formation can be rationalized via a plausible mechanism depicted in Scheme [²] . It is conceivable that the initial step is the formation of the imine 5 followed by formation of the intermediate 6 through a nucleophilic attack of the base-activated TosMIC to the imine polarized double bond. Subsequent ring closure by intramolecular nucleophilic attack of the second NH2 group and loss of the tosyl moiety leads to the tetrahydroquinoxaline intermediate 7, from which by oxidation the more stable quinoxaline derivative 3 can be formed. [²8]
Regarding the structure of compounds 3, although they are known (with exception of 3f, 3i and 3m), perusal in the literature revealed no reported assignment of NMR signals to the corresponding atoms. Therefore, a full assignment of signals to corresponding atoms in the case of compound 3e is described, [²9] based on COSY H-H, XHCORR and COLOC spectral data. In Figure [¹] the C-H COLOC correlations via ³ J CH are depicted.

Scheme 2 Plausible mechanism for the formation of quinoxalines 3

Figure 1 Diagnostic COLOC correlations between protons and carbons via ³ J C-H in compound 3e
The one-step synthesis reported herein offers a very convenient and conceptually new alternative to combinatorial synthesis of 2-arylquinoxalines. In addition, the otherwise difficult-to-access quinoxalines, bearing in the 2-position a heterocyclic ring, are isolated in good yields. To the best of our knowledge this new multicomponent reaction constitutes the first example of an aniline-like amino group functioning as internal nucleophile to intercept the TosMIC moiety interacting with an imine moiety. Moreover, the studied reactions constitute the first example wherein TosMIC reacts in this unique way, contributing only one carbon to the reaction.
In summary, we have described a multicomponent reaction leading to quinoxalines from simple, readily available and easy to handle precursors. This reaction can be extended to heterocyclic 1,2-diamines and N-monoalkylated diamines.
- 1a
Cheeseman GW.Cookson RF. In The Chemistry of Heterocyclic Compounds 2nd ed.:Weissberger A.Taylor EC. Wiley; New York: 1979. p.1 - 1b
Toshima K.Ozawa T.Kimura T.Matsumura S. Bioorg. Med. Chem. Lett. 2004, 14: 2777 - 1c
Carta A.Paglietti G.Nikookar MER.Sanna P.Sechi L.Zanetti S. Eur. J. Med. Chem. 2002, 37: 355 - 2a
Piras S.Loriga M.Paglietti G. Farmaco 2004, 59: 185 - 2b
Carta A.Loriga M.Zanetti S.Sechi LA. Farmaco 2003, 58: 1251 - 3
Ali MM.Ismail MMF.El-Gaby MSA.Zahran MA.Ammar YA. Molecules 2000, 5: 864 - 4
Sarges R.Howard HR.Browne RG.Lebel LA.Seymour PA.Koe BK. J. Med. Chem. 1990, 33: 2240 - 5
Sakata G.Makino K.Kurasawa Y. Heterocycles 1998, 27: 2481 - 6
Gomtsyan A.Bayburt EK.Schmidt RG.Zeng GZ.Perner RJ.Didomenico S.Koenig JR.Turner S.Jinkerson T.Drizin I.Hannick SM.Macri BS.McDonald HA.Honore P.Wismer CT.Marsh KC.Wetter J.Stewart KD.Oie T.Jarvis MF.Surowy CS.Faltynek CR.Lee C.-H. J. Med. Chem. 2005, 48: 744 - 7
Seitz LE.Suling WJ.Reynolds RC. J. Med. Chem. 2002, 45: 5604 - 8
Jaso A.Zarranz B.Aldana I.Monge A. J. Med. Chem. 2005, 48: 2019 - 9
He W.Myers MR.Hanney B.Spada AP.Bilder G.Galzcinski H.Amin D.Needle S.Page K.Jayyosi Z.Perrone MH. Bioorg. Med. Chem. Lett. 2003, 13: 3097 - 10
Kim YB.Kim YH.Park JY.Kim SK. Bioorg. Med. Chem. Lett. 2004, 14: 541 - 11
Myers MR.He W.Hanney B.Setzer N.Maguire MP.Zulli A.Bilder G.Galzcinski H.Amin D.Needle S.Spada AP. Bioorg. Med. Chem. Lett. 2003, 13: 3091 - 12
Pearlman WM. Org. Synth. 1969, 49: 75 - 13a
Katoh A.Yoshida T.Ohkanda J. In Heterocycles 2000, 52: 911 - 13b
Thomas KRJ.Velusamy M.Lin JT.Chuen C.-H.Tao Y.-T. Chem. Mater. 2005, 17: 1860 - 13c
Dailey S.Feast WJ.Peace RJ.Sage IC.Till S.Wood EL. J. Mater. Chem. 2001, 11: 2238 - 13d
Sascha O.Rüdiger F. Synlett 2004, 1509 - 13e
Sessler JL.Maeda H.Mizuno T.Lynch VM.Furuta H. J. Am. Chem. Soc. 2002, 124: 13474 - 13f
Crossley MJ.Johnston LA. Chem. Commun. 2002, 1122 - 14a
Brown DJ. Quinoxalines Supplements II, In The Chemistry of Heterocyclic CompoundsTaylor EC.Wipf P. John Wiley & Sons; New Jersey: 2004. - 14b
Bhosale RS.Sarda SR.Ardhapure SS.Jadhav WN.Bhusare SR.Pawar RP. Tetrahedron Lett. 2005, 46: 7183 - 14c
More SV.Sastry MNV.Yao C.-F. Green Chem. 2006, 8: 91 - 14d
Zhao Z.Wisnoski DD.Wolkenberg SE.Leister WH.Wang Y.Lindsley CW. Tetrahedron Lett. 2004, 45: 4873 - 15
Aparicio D.Attanasi OA.Filippone P.Ignacio R.Lillini S.Mantellini F.Palacios F.De los Santos JM. J. Org. Chem. 2006, 71: 5897 - 16a
Raw SA.Wilfred CD.Taylor RJK. Org. Biomol. Chem. 2004, 2: 788 - 16b
Kim SY.Park KH.Chung YK. Chem. Commun. 2005, 1321 - 16c
Robinson RS.Taylor RJK. Synlett 2005, 1003 - 16d
Cho CS.Oh SG. J. Mol. Catal. A: Chem. 2007, 276: 205 - 16e
Shaabani A.Maleki A. Chem. Pharm. Bull. 2008, 56: 79 - 17a
Singh SK.Gupta P.Duggineni S.Kundu B. Synlett 2003, 2147 - 17b
Das B.Venkateswarlu K.Suneel K.Majhi A. Tetrahedron Lett. 2007, 48: 5371 - 18
Cho CS.Oh SG. Tetrahedron Lett. 2006, 47: 5633 - 19a
Antoniotti S.Duñach E. Tetrahedron Lett. 2002, 43: 3971 - 19b
Nasar MK.Kumar RR.Perumal S. Tetrahedron Lett. 2007, 48: 2155 - 20
Cho CS.Ren WX.Shim SC. Tetrahedron Lett. 2007, 48: 4665 - 21
Krasavin M.Parchinsky V. Synlett 2008, 645 - 22a
Dömling A.Ugi I. Angew. Chem. Int. Ed. 2000, 39: 3168 - 22b
Dömling A. Chem. Rev. 2006, 106: 17 - 22c
Tietze LF. Chem. Rev. 1996, 96: 115 - 22d
Posner GH. Chem. Rev. 1986, 86: 831 - 22e
Ramón DJ.Yus M. Angew. Chem. Int. Ed. 2005, 44: 1602 - 23
Bienaymé H.Hulme C.Oddon G.Schmitt P. Chem. Eur. J. 2000, 6: 3321 - 24a
Van Leusen D.Van Leusen AM. Org. React. 2001, 57: 417 - 24b
Tandon VK.Rai S. Sulfur Reports 2003, 24: 307 - 25a
Denmark SE.Fan Y. J. Org. Chem. 2005, 70: 9667 - 25b
Krishna PR.Dayaker G.Reddy PVN. Tetrahedron Lett. 2006, 47: 5977 - 26a
Sisko J.Kassick AJ.Mellinger M.Filan JJ.Allen A.Olsen MA. J. Org. Chem. 2000, 65: 1516 - 26b
Ten-Have R.Huisman M.Meetsma A.Van Leusen AM. Tetrahedron 1997, 33: 11355 - 26c
Beck B.Leppert CA.Mueller BK.Dömling A. QSAR Com. Sci. 2006, 25: 527 - 27
Terzidis M.Tsoleridis CA.Stephanidou-Stephanatou J. Tetrahedron 2007, 63: 7828 - 30
Higashino T.Takemoto M.Tanji K.-I.Iijima C.Hayashi E. Chem. Pharm. Bull. 1985, 33: 4193
References and Notes
Evolution of gas with alkaline pH and characteristic amine odor was detected.
29All melting points were determined
on a Büchi apparatus and are uncorrected. The ¹H
NMR and ¹³C NMR spectra were recorded
on a Bruker AM 300 spectrometer in CDCl3 with TMS as
internal standard. All coupling constants are given in Hz and chemical
shifts are given in ppm.
Typical Experimental
Procedure for the Preparation of 3e: To a stirred solution
of o-phenylenediamine (1a;
1.0 mmol) in toluene (20 mL), 4-chlorobenzaldehyde (1.0 mmol) was
added and stirring was continued for 5 min. Then TosMIC (1.0 mmol)
and DABCO (1.2 mmol) were added and the reaction mixture was heated
to 80 ˚C for 4 h. The resulting solution was initially
washed with 5% HCl, then with H2O and dried.
The solvent was distilled off under reduced pressure to yield the
corresponding crude product mixture, which was purified by silica
gel chromatography using petroleum ether-EtOAc (10:1) as
eluent, to give quinoxaline 3e in 84% yield;
yellow crystals; mp 136-
137 ˚C (ethanol)
(lit.
[³0]
137 ˚C). ¹H
NMR: δ = 7.51 (dd, J = 8.8,
2.1 Hz, 2 H, 3′-H, 5′-H), 7.74 (dd, J = 8.8, 2.1 Hz, 1 H, 7-H),
[³¹]
7.77 (dd, J = 8.8, 2.1 Hz, 1 H, 6-H),
8.10 (dd, J = 8.8, 2.1 Hz, 1
H, 5-H), 8.11 (dd, J = 8.8,
2.1 Hz, 1 H, 8-H), 8.12 (dd, J = 8.8,
2.0 Hz, 2 H, 2′-H, 6′-H), 9.27 (s, 1 H, 3-H).
¹³C
NMR: δ = 128.7 (C-2′, C-6′),
129.1 (C-5), 129.4 (C-3′, C-5′), 129.5 (C-8),
129.8 (C-7), 130.4 (C-6), 135.1 (C-1′), 136.5 (C-4′),
141.6 (C-4a), 142.1 (C-8a), 150.5 (C-2). Anal. Calcd for C14H9ClN2 (240.69):
C, 69.85; H, 3.74; N, 11.64. Found: C, 70.01; H, 3.83; N, 11.68.
The multiplicities and chemical shifts
of the aromatic protons have been confirmed after simulation with
program SpinWorks, version 2.5, available from
ftp://davinci.chem.umanitoba.ca.
- 1a
Cheeseman GW.Cookson RF. In The Chemistry of Heterocyclic Compounds 2nd ed.:Weissberger A.Taylor EC. Wiley; New York: 1979. p.1 - 1b
Toshima K.Ozawa T.Kimura T.Matsumura S. Bioorg. Med. Chem. Lett. 2004, 14: 2777 - 1c
Carta A.Paglietti G.Nikookar MER.Sanna P.Sechi L.Zanetti S. Eur. J. Med. Chem. 2002, 37: 355 - 2a
Piras S.Loriga M.Paglietti G. Farmaco 2004, 59: 185 - 2b
Carta A.Loriga M.Zanetti S.Sechi LA. Farmaco 2003, 58: 1251 - 3
Ali MM.Ismail MMF.El-Gaby MSA.Zahran MA.Ammar YA. Molecules 2000, 5: 864 - 4
Sarges R.Howard HR.Browne RG.Lebel LA.Seymour PA.Koe BK. J. Med. Chem. 1990, 33: 2240 - 5
Sakata G.Makino K.Kurasawa Y. Heterocycles 1998, 27: 2481 - 6
Gomtsyan A.Bayburt EK.Schmidt RG.Zeng GZ.Perner RJ.Didomenico S.Koenig JR.Turner S.Jinkerson T.Drizin I.Hannick SM.Macri BS.McDonald HA.Honore P.Wismer CT.Marsh KC.Wetter J.Stewart KD.Oie T.Jarvis MF.Surowy CS.Faltynek CR.Lee C.-H. J. Med. Chem. 2005, 48: 744 - 7
Seitz LE.Suling WJ.Reynolds RC. J. Med. Chem. 2002, 45: 5604 - 8
Jaso A.Zarranz B.Aldana I.Monge A. J. Med. Chem. 2005, 48: 2019 - 9
He W.Myers MR.Hanney B.Spada AP.Bilder G.Galzcinski H.Amin D.Needle S.Page K.Jayyosi Z.Perrone MH. Bioorg. Med. Chem. Lett. 2003, 13: 3097 - 10
Kim YB.Kim YH.Park JY.Kim SK. Bioorg. Med. Chem. Lett. 2004, 14: 541 - 11
Myers MR.He W.Hanney B.Setzer N.Maguire MP.Zulli A.Bilder G.Galzcinski H.Amin D.Needle S.Spada AP. Bioorg. Med. Chem. Lett. 2003, 13: 3091 - 12
Pearlman WM. Org. Synth. 1969, 49: 75 - 13a
Katoh A.Yoshida T.Ohkanda J. In Heterocycles 2000, 52: 911 - 13b
Thomas KRJ.Velusamy M.Lin JT.Chuen C.-H.Tao Y.-T. Chem. Mater. 2005, 17: 1860 - 13c
Dailey S.Feast WJ.Peace RJ.Sage IC.Till S.Wood EL. J. Mater. Chem. 2001, 11: 2238 - 13d
Sascha O.Rüdiger F. Synlett 2004, 1509 - 13e
Sessler JL.Maeda H.Mizuno T.Lynch VM.Furuta H. J. Am. Chem. Soc. 2002, 124: 13474 - 13f
Crossley MJ.Johnston LA. Chem. Commun. 2002, 1122 - 14a
Brown DJ. Quinoxalines Supplements II, In The Chemistry of Heterocyclic CompoundsTaylor EC.Wipf P. John Wiley & Sons; New Jersey: 2004. - 14b
Bhosale RS.Sarda SR.Ardhapure SS.Jadhav WN.Bhusare SR.Pawar RP. Tetrahedron Lett. 2005, 46: 7183 - 14c
More SV.Sastry MNV.Yao C.-F. Green Chem. 2006, 8: 91 - 14d
Zhao Z.Wisnoski DD.Wolkenberg SE.Leister WH.Wang Y.Lindsley CW. Tetrahedron Lett. 2004, 45: 4873 - 15
Aparicio D.Attanasi OA.Filippone P.Ignacio R.Lillini S.Mantellini F.Palacios F.De los Santos JM. J. Org. Chem. 2006, 71: 5897 - 16a
Raw SA.Wilfred CD.Taylor RJK. Org. Biomol. Chem. 2004, 2: 788 - 16b
Kim SY.Park KH.Chung YK. Chem. Commun. 2005, 1321 - 16c
Robinson RS.Taylor RJK. Synlett 2005, 1003 - 16d
Cho CS.Oh SG. J. Mol. Catal. A: Chem. 2007, 276: 205 - 16e
Shaabani A.Maleki A. Chem. Pharm. Bull. 2008, 56: 79 - 17a
Singh SK.Gupta P.Duggineni S.Kundu B. Synlett 2003, 2147 - 17b
Das B.Venkateswarlu K.Suneel K.Majhi A. Tetrahedron Lett. 2007, 48: 5371 - 18
Cho CS.Oh SG. Tetrahedron Lett. 2006, 47: 5633 - 19a
Antoniotti S.Duñach E. Tetrahedron Lett. 2002, 43: 3971 - 19b
Nasar MK.Kumar RR.Perumal S. Tetrahedron Lett. 2007, 48: 2155 - 20
Cho CS.Ren WX.Shim SC. Tetrahedron Lett. 2007, 48: 4665 - 21
Krasavin M.Parchinsky V. Synlett 2008, 645 - 22a
Dömling A.Ugi I. Angew. Chem. Int. Ed. 2000, 39: 3168 - 22b
Dömling A. Chem. Rev. 2006, 106: 17 - 22c
Tietze LF. Chem. Rev. 1996, 96: 115 - 22d
Posner GH. Chem. Rev. 1986, 86: 831 - 22e
Ramón DJ.Yus M. Angew. Chem. Int. Ed. 2005, 44: 1602 - 23
Bienaymé H.Hulme C.Oddon G.Schmitt P. Chem. Eur. J. 2000, 6: 3321 - 24a
Van Leusen D.Van Leusen AM. Org. React. 2001, 57: 417 - 24b
Tandon VK.Rai S. Sulfur Reports 2003, 24: 307 - 25a
Denmark SE.Fan Y. J. Org. Chem. 2005, 70: 9667 - 25b
Krishna PR.Dayaker G.Reddy PVN. Tetrahedron Lett. 2006, 47: 5977 - 26a
Sisko J.Kassick AJ.Mellinger M.Filan JJ.Allen A.Olsen MA. J. Org. Chem. 2000, 65: 1516 - 26b
Ten-Have R.Huisman M.Meetsma A.Van Leusen AM. Tetrahedron 1997, 33: 11355 - 26c
Beck B.Leppert CA.Mueller BK.Dömling A. QSAR Com. Sci. 2006, 25: 527 - 27
Terzidis M.Tsoleridis CA.Stephanidou-Stephanatou J. Tetrahedron 2007, 63: 7828 - 30
Higashino T.Takemoto M.Tanji K.-I.Iijima C.Hayashi E. Chem. Pharm. Bull. 1985, 33: 4193
References and Notes
Evolution of gas with alkaline pH and characteristic amine odor was detected.
29All melting points were determined
on a Büchi apparatus and are uncorrected. The ¹H
NMR and ¹³C NMR spectra were recorded
on a Bruker AM 300 spectrometer in CDCl3 with TMS as
internal standard. All coupling constants are given in Hz and chemical
shifts are given in ppm.
Typical Experimental
Procedure for the Preparation of 3e: To a stirred solution
of o-phenylenediamine (1a;
1.0 mmol) in toluene (20 mL), 4-chlorobenzaldehyde (1.0 mmol) was
added and stirring was continued for 5 min. Then TosMIC (1.0 mmol)
and DABCO (1.2 mmol) were added and the reaction mixture was heated
to 80 ˚C for 4 h. The resulting solution was initially
washed with 5% HCl, then with H2O and dried.
The solvent was distilled off under reduced pressure to yield the
corresponding crude product mixture, which was purified by silica
gel chromatography using petroleum ether-EtOAc (10:1) as
eluent, to give quinoxaline 3e in 84% yield;
yellow crystals; mp 136-
137 ˚C (ethanol)
(lit.
[³0]
137 ˚C). ¹H
NMR: δ = 7.51 (dd, J = 8.8,
2.1 Hz, 2 H, 3′-H, 5′-H), 7.74 (dd, J = 8.8, 2.1 Hz, 1 H, 7-H),
[³¹]
7.77 (dd, J = 8.8, 2.1 Hz, 1 H, 6-H),
8.10 (dd, J = 8.8, 2.1 Hz, 1
H, 5-H), 8.11 (dd, J = 8.8,
2.1 Hz, 1 H, 8-H), 8.12 (dd, J = 8.8,
2.0 Hz, 2 H, 2′-H, 6′-H), 9.27 (s, 1 H, 3-H).
¹³C
NMR: δ = 128.7 (C-2′, C-6′),
129.1 (C-5), 129.4 (C-3′, C-5′), 129.5 (C-8),
129.8 (C-7), 130.4 (C-6), 135.1 (C-1′), 136.5 (C-4′),
141.6 (C-4a), 142.1 (C-8a), 150.5 (C-2). Anal. Calcd for C14H9ClN2 (240.69):
C, 69.85; H, 3.74; N, 11.64. Found: C, 70.01; H, 3.83; N, 11.68.
The multiplicities and chemical shifts
of the aromatic protons have been confirmed after simulation with
program SpinWorks, version 2.5, available from
ftp://davinci.chem.umanitoba.ca.

Scheme 1 Reagents and conditions: DBU or DABCO, toluene 80 ˚C, 4 h

Scheme 2 Plausible mechanism for the formation of quinoxalines 3

Figure 1 Diagnostic COLOC correlations between protons and carbons via ³ J C-H in compound 3e